Langer CJ, Mehta MP (2005) Current management of brain metastases, with a focus on systemic options. J Clin Oncol 23:6207–6219. https://doi.org/10.1200/JCO.2005.03.145

Article  CAS  PubMed  Google Scholar 

Yu Y, Chen H, Tian Z, Zhang Q, Shui Y, Shen L, Hu Q, Huang Z, Zhu S, Jiang H, Wei Q (2023) Improved survival outcome with not-delayed radiotherapy and immediate PD-1/PD-L1 inhibitor for non-small-cell lung cancer patients with brain metastases. J Neurooncol 165:127–137. https://doi.org/10.1007/s11060-023-04459-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zach L, Guez D, Last D, Daniels D, Grober Y, Nissim O, Hoffmann C, Nass D, Talianski A, Spiegelmann R, Tsarfaty G, Salomon S, Hadani M, Kanner A, Blumenthal DT, Bukstein F, Yalon M, Zauberman J, Roth J, Shoshan Y, Fridman E, Wygoda M, Limon D, Tzuk T, Cohen ZR, Mardor Y (2015) Delayed contrast extravasation MRI: a new paradigm in neuro-oncology. Neuro Oncol 17:457–465. https://doi.org/10.1093/neuonc/nou230

Article  CAS  PubMed  Google Scholar 

Ellingson BM, Chung C, Pope WB, Boxerman JL, Kaufmann TJ (2017) Pseudoprogression, radionecrosis, inflammation or true tumor progression? Challenges associated with Glioblastoma response assessment in an evolving therapeutic landscape. J Neurooncol 134:495–504. https://doi.org/10.1007/s11060-017-2375-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manning P, Daghighi S, Rajaratnam MK, Parthiban S, Bahrami N, Dale AM, Bolar D, Piccioni DE, McDonald CR, Farid N (2020) Differentiation of progressive disease from pseudoprogression using 3D PCASL and DSC perfusion MRI in patients with glioblastoma. J Neurooncol 147:681–690. https://doi.org/10.1007/s11060-020-03475-y

Article  PubMed  Google Scholar 

Thomas AA, Arevalo-Perez J, Kaley T, Lyo J, Peck KK, Shi W, Zhang Z, Young RJ (2015) Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma. J Neurooncol 125:183–190. https://doi.org/10.1007/s11060-015-1893-z

Article  PubMed  PubMed Central  Google Scholar 

Umemura Y, Wang D, Peck KK, Flynn J, Zhang Z, Fatovic R, Anderson ES, Beal K, Shoushtari AN, Kaley T, Young RJ (2020) DCE-MRI perfusion predicts pseudoprogression in metastatic melanoma treated with immunotherapy. J Neurooncol 146:339–346. https://doi.org/10.1007/s11060-019-03379-6

Article  CAS  PubMed  Google Scholar 

Bodensohn R, Forbrig R, Quach S, Reis J, Boulesteix AL, Mansmann U, Hadi I, Fleischmann DF, Mucke J, Holzgreve A, Albert NL, Ruf V, Dorostkar M, Corradini S, Herms J, Belka C, Thon N, Niyazi M (2022) MRI-based contrast clearance analysis shows high differentiation accuracy between radiation-induced reactions and progressive disease after cranial radiotherapy. ESMO Open 7:100424. https://doi.org/10.1016/j.esmoop.2022.100424

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lim DH, Kim SY, Na YC, Cho JM (2023) Navigation guided Biopsy is as effective as Frame-based stereotactic biopsy. J Pers Med 13. https://doi.org/10.3390/jpm13050708

Mohamedkhan S, Hindocha S, de Boisanger J, Millard T, Welsh L, Rich P, MacKinnon AD, Williams N, Sharma B, Rosenfelder N, Minchom A (2024) Contrast Clearance Analysis (CCA) to assess viable Tumour following stereotactic radiosurgery (SRS) to Brain Metastasis in Non-small Cell Lung Cancer (NSCLC). Cancers (Basel) 16. https://doi.org/10.3390/cancers16061218

Zach L, Guez D, Last D, Daniels D, Grober Y, Nissim O, Hoffmann C, Nass D, Talianski A, Spiegelmann R, Cohen ZR, Mardor Y (2012) Delayed contrast extravasation MRI for depicting tumor and non-tumoral tissues in primary and metastatic brain tumors. PLoS ONE 7:e52008. https://doi.org/10.1371/journal.pone.0052008

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rachinger W, Stoecklein VM, Terpolilli NA, Haug AR, Ertl L, Poschl J, Schuller U, Schichor C, Thon N, Tonn JC (2015) Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue. J Nucl Med 56:347–353. https://doi.org/10.2967/jnumed.114.149120

Article  CAS  PubMed  Google Scholar 

Chen WC, Perlow HK, Choudhury A, Nguyen MP, Mirchia K, Youngblood MW, Lucas CG, Palmer JD, Magill ST, Raleigh DR (2022) Radiotherapy for meningiomas. J Neurooncol 160:505–515. https://doi.org/10.1007/s11060-022-04171-9

Article  PubMed  PubMed Central  Google Scholar